SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2003 JOHNSON & JOHNSON (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or other Commission (I.R.S. Employer jurisdiction File Number) Identification No.) of incorporation) One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (Address of principal executive offices) (zip code) Registrant's telephone number including area code: (732) 524-0400 Item 5. Other Events. On January 24, 2003, Johnson & Johnson ("J&J") issued a press release statement on the Amgen arbitration fees and expenses. Exhibit 99.15 of this Form 8K reflects this press release amended to include the accrual of the Amgen arbitration and fees recorded as part of 2002 financial results. The unaudited consolidated statements of earnings of J&J for the fourth quarter and year ended December 29, 2002 reflecting the results of the Amgen arbitration fees and expenses is being filed as Exhibit 99.2O to this Form 8K. On January 22, 2003, John Snow resigned from the Board of Directors in connection with his nomination by President Bush to serve as U.S. Secretary of the Treasury. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (c) Exhibits Exhibit No. Description of Exhibit 99.15 Press Release on Amgen arbitration fees and expenses. 99.2O Unaudited consolidated statements of earnings for the fourth quarter and year ended December 29, 2002 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JOHNSON & JOHNSON Date: January 30, 2003 By: /s/ Stephen J. Cosgrove Stephen J. Cosgrove Chief Accounting Officer